Skip to main content

Table 1 Distribution of ST among study isolates

From: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat,

ST

Clade

n (%)

ST42

1

39 (12.5)

ST2

1

36 (11.5)

ST104

1

23 (7.3)

ST11

5

21 (6.7)

ST3

1

13 (4.2)

ST34

1

9 (2.9)

ST54

1

9 (2.9)

ST55

1

9 (2.9)

ST37

4

8 (2.6)

ST13

1

7 (2.2)

Others

1, 2, 3, 4

108 (34.5)

Unclassified

N.A.

31 (9.9)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us